Literature DB >> 23462423

Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer.

Clemens Grassberger1, Stephen Dowdell, Antony Lomax, Greg Sharp, James Shackleford, Noah Choi, Henning Willers, Harald Paganetti.   

Abstract

PURPOSE: To quantify the impact of respiratory motion on the treatment of lung tumors with spot scanning proton therapy. METHODS AND MATERIALS: Four-dimensional Monte Carlo simulations were used to assess the interplay effect, which results from relative motion of the tumor and the proton beam, on the dose distribution in the patient. Ten patients with varying tumor sizes (2.6-82.3 cc) and motion amplitudes (3-30 mm) were included in the study. We investigated the impact of the spot size, which varies between proton facilities, and studied single fractions and conventionally fractionated treatments. The following metrics were used in the analysis: minimum/maximum/mean dose, target dose homogeneity, and 2-year local control rate (2y-LC).
RESULTS: Respiratory motion reduces the target dose homogeneity, with the largest effects observed for the highest motion amplitudes. Smaller spot sizes (σ ≈ 3 mm) are inherently more sensitive to motion, decreasing target dose homogeneity on average by a factor 2.8 compared with a larger spot size (σ ≈ 13 mm). Using a smaller spot size to treat a tumor with 30-mm motion amplitude reduces the minimum dose to 44.7% of the prescribed dose, decreasing modeled 2y-LC from 87.0% to 2.7%, assuming a single fraction. Conventional fractionation partly mitigates this reduction, yielding a 2y-LC of 71.6%. For the large spot size, conventional fractionation increases target dose homogeneity and prevents a deterioration of 2y-LC for all patients. No correlation with tumor volume is observed. The effect on the normal lung dose distribution is minimal: observed changes in mean lung dose and lung V20 are <0.6 Gy(RBE) and <1.7%, respectively.
CONCLUSIONS: For the patients in this study, 2y-LC could be preserved in the presence of interplay using a large spot size and conventional fractionation. For treatments using smaller spot sizes and/or in the delivery of single fractions, interplay effects can lead to significant deterioration of the dose distribution and lower 2y-LC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23462423      PMCID: PMC3646997          DOI: 10.1016/j.ijrobp.2013.01.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Dosimetric consequences of tumour motion due to respiration for a scanned proton beam.

Authors:  K M Kraus; E Heath; U Oelfke
Journal:  Phys Med Biol       Date:  2011-09-21       Impact factor: 3.609

3.  A case study in proton pencil-beam scanning delivery.

Authors:  Hanne M Kooy; Benjamin M Clasie; Hsiao-Ming Lu; Thomas M Madden; Hassan Bentefour; Nicolas Depauw; Judy A Adams; Alexei V Trofimov; Denis Demaret; Thomas F Delaney; Jacob B Flanz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

4.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.

Authors:  Xiaodong Zhang; Yupeng Li; Xiaoning Pan; Li Xiaoqiang; Radhe Mohan; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-05       Impact factor: 7.038

5.  Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer.

Authors:  Joe Y Chang; Ritsuko Komaki; Hong Y Wen; Beth De Gracia; Jaques B Bluett; Mary F McAleer; Stephen G Swisher; Michael Gillin; Radhe Mohan; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-20       Impact factor: 7.038

6.  4D Proton treatment planning strategy for mobile lung tumors.

Authors:  Yixiu Kang; Xiaodong Zhang; Joe Y Chang; He Wang; Xiong Wei; Zhongxing Liao; Ritsuko Komaki; James D Cox; Peter A Balter; Helen Liu; X Ronald Zhu; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-01       Impact factor: 7.038

7.  Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.

Authors:  Joe Y Chang; Ritsuko Komaki; Charles Lu; Hong Y Wen; Pamela K Allen; Anne Tsao; Michael Gillin; Radhe Mohan; James D Cox
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

8.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.

Authors:  Jochen Willner; Kurt Baier; Ekaterini Caragiani; Axel Tschammler; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

9.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

10.  Quantification of interplay effects of scanned particle beams and moving targets.

Authors:  Christoph Bert; Sven O Grözinger; Eike Rietzel
Journal:  Phys Med Biol       Date:  2008-04-09       Impact factor: 3.609

View more
  53 in total

1.  Computing proton dose to irregularly moving targets.

Authors:  Justin Phillips; Gueorgui Gueorguiev; James A Shackleford; Clemens Grassberger; Stephen Dowdell; Harald Paganetti; Gregory C Sharp
Journal:  Phys Med Biol       Date:  2014-07-16       Impact factor: 3.609

2.  Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Authors:  Joe Y Chang; Heng Li; X Ronald Zhu; Zhongxing Liao; Lina Zhao; Amy Liu; Yupeng Li; Narayan Sahoo; Falk Poenisch; Daniel R Gomez; Richard Wu; Michael Gillin; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-24       Impact factor: 7.038

3.  Motion mitigation for lung cancer patients treated with active scanning proton therapy.

Authors:  Clemens Grassberger; Stephen Dowdell; Greg Sharp; Harald Paganetti
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

4.  Intensity modulated proton therapy.

Authors:  H M Kooy; C Grassberger
Journal:  Br J Radiol       Date:  2015-05-27       Impact factor: 3.039

5.  On the interplay effects with proton scanning beams in stage III lung cancer.

Authors:  Yupeng Li; Laleh Kardar; Xiaoqiang Li; Heng Li; Wenhua Cao; Joe Y Chang; Li Liao; Ronald X Zhu; Narayan Sahoo; Michael Gillin; Zhongxing Liao; Ritsuko Komaki; James D Cox; Gino Lim; Xiaodong Zhang
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

6.  Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence.

Authors:  Heng Li; X Ronald Zhu; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-18       Impact factor: 7.038

7.  Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.

Authors:  Laleh Kardar; Yupeng Li; Xiaoqiang Li; Heng Li; Wenhua Cao; Joe Y Chang; Li Liao; Ronald X Zhu; Narayan Sahoo; Michael Gillin; Zhongxing Liao; Ritsuko Komaki; James D Cox; Gino Lim; Xiaodong Zhang
Journal:  Pract Radiat Oncol       Date:  2014-08-12

8.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

9.  Four-dimensional Monte Carlo simulations demonstrating how the extent of intensity-modulation impacts motion effects in proton therapy lung treatments.

Authors:  Stephen Dowdell; Clemens Grassberger; Harald Paganetti
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

10.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.